A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors
Clinical trial NCT04452955 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04452955
- Sponsor
- Intra-IMMUSG Pte Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-12
- Primary completion
- 2026-12-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.